Apimeds Pharmaceuticals US, Inc (APUS) Stock Price History
Historical prices from 2025 to 2026
- 1M
- -34.4%
- 3M
- -47.1%
- YTD
- -44.6%
- 1Y
- -47.4%
- 3Y
- -25.1%
- 5Y
- -15.9%
Loading 10-year price history...
APUS Historical Performance
APUS Annual Returns
Year-by-year price performance · 2025–2026
- 2025 annual price return
- -25.5%
- 2026 annual price return
- -18.3%
APUS Stock Price Trajectory (2025–2026)
As of June 30, 2026, Apimeds Pharmaceuticals US, Inc (APUS) trades at $0.93, representing a -47.4% return over the past year. The stock has delivered a -59.5% total return over five years (-15.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $5.97 on May 5, 2026. From this peak, APUS has corrected -84.5%, currently trading 48% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers HALO (+48.4% 1Y), ACRS (+253.5% 1Y), and SLRX (-94.5% 1Y), APUS has underperformed the peer group average. Compare APUS vs HALO →
APUS Historical Price Data · from 2025
Rows 1–50 of 276| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-06-29 | 0.90 | 1.09 | 0.84 | 0.93 | 17K | +2.78% |
| 2026-06-26 | 1.00 | 1.07 | 0.85 | 0.90 | 807 | +0.67% |
| 2026-06-25 | 0.90 | 1.00 | 0.82 | 0.89 | 308K | +0.45% |
| 2026-06-24 | 0.99 | 1.00 | 0.88 | 0.89 | 103K | +2.77% |
| 2026-06-23 | 0.87 | 0.94 | 0.85 | 0.87 | 31K | -2.71% |
| 2026-06-22 | 1.55 | 1.55 | 0.89 | 0.89 | 211K | -18.34% |
| 2026-06-18 | 1.20 | 1.32 | 1.07 | 1.09 | 61K | -15.18% |
| 2026-06-17 | 1.20 | 1.29 | 1.19 | 1.28 | 33K | +7.98% |
| 2026-06-16 | 1.40 | 1.40 | 1.19 | 1.19 | 79K | -11.19% |
| 2026-06-15 | 1.22 | 1.36 | 1.22 | 1.34 | 45K | +0.75% |
| 2026-06-12 | 1.55 | 1.55 | 1.21 | 1.33 | 24K | +6.40% |
| 2026-06-11 | 1.55 | 1.55 | 1.24 | 1.25 | 22K | -3.10% |
| 2026-06-10 | 1.33 | 1.33 | 1.26 | 1.29 | 8K | -3.73% |
| 2026-06-09 | 1.10 | 1.36 | 1.10 | 1.34 | 27K | +4.69% |
| 2026-06-08 | 1.17 | 1.28 | 1.17 | 1.28 | 18K | +0.79% |
| 2026-06-05 | 1.44 | 1.44 | 1.25 | 1.27 | 20K | -9.93% |
| 2026-06-04 | 1.35 | 1.50 | 1.35 | 1.41 | 58K | +4.44% |
| 2026-06-03 | 1.47 | 1.50 | 1.34 | 1.35 | 68K | +2.27% |
| 2026-06-02 | 1.43 | 1.51 | 1.32 | 1.32 | 25K | -13.16% |
| 2026-06-01 | 1.50 | 1.53 | 1.36 | 1.52 | 31K | +7.80% |
| 2026-05-29 | 1.35 | 1.49 | 1.35 | 1.41 | 13K | +2.92% |
| 2026-05-28 | 1.50 | 1.50 | 1.29 | 1.37 | 43K | -3.52% |
| 2026-05-27 | 1.51 | 1.60 | 1.41 | 1.42 | 59K | 0.00% |
| 2026-05-26 | 1.50 | 1.53 | 1.38 | 1.42 | 34K | -5.33% |
| 2026-05-22 | 1.37 | 1.55 | 1.37 | 1.50 | 38K | +7.14% |
| 2026-05-21 | 1.50 | 1.50 | 1.38 | 1.40 | 20K | +0.72% |
| 2026-05-20 | 1.29 | 1.42 | 1.29 | 1.39 | 25K | -2.11% |
| 2026-05-19 | 1.49 | 1.49 | 1.37 | 1.42 | 17K | -4.70% |
| 2026-05-18 | 1.51 | 1.51 | 1.44 | 1.49 | 36K | +2.05% |
| 2026-05-15 | 1.34 | 1.51 | 1.34 | 1.46 | 66K | +8.96% |
| 2026-05-14 | 1.33 | 1.34 | 1.24 | 1.34 | 107K | +3.08% |
| 2026-05-13 | 1.33 | 1.39 | 1.30 | 1.30 | 50K | -2.99% |
| 2026-05-12 | 1.44 | 1.45 | 1.31 | 1.34 | 19K | -8.22% |
| 2026-05-11 | 1.45 | 1.57 | 1.34 | 1.46 | 161K | -3.53% |
| 2026-05-08 | 1.51 | 1.59 | 1.44 | 1.51 | 165K | +2.96% |
| 2026-05-07 | 1.92 | 1.94 | 1.40 | 1.47 | 560K | -24.62% |
| 2026-05-06 | 2.14 | 2.34 | 1.95 | 1.95 | 760K | -35.00% |
| 2026-05-05 | 1.90 | 5.97 | 1.90 | 3.00 | 4.20M | +59.57% |
| 2026-04-20 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-17 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-16 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-15 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-14 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-13 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-10 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-09 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-08 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-07 | 1.88 | 1.88 | 1.88 | 1.88 | 0 | 0.00% |
| 2026-04-06 | 1.88 | 1.88 | 1.88 | 1.88 | 32K | 0.00% |
| 2026-04-02 | 1.69 | 1.89 | 1.69 | 1.88 | 32K | +7.43% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
APUS — Frequently Asked Questions
Quick answers to the most common questions about buying APUS stock.
How has APUS stock performed recently?
APUS declined -47.4% over the past year, below its 5-year annualized CAGR of -15.9%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is APUS's all-time high price?
Apimeds Pharmaceuticals US, Inc reached $5.97 on 2026-05-05. The 52-week high is $5.97. Current 1-year return of -47.4% places the stock further from historical peaks.
Where can I download APUS historical price data?
This page provides APUS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2025-2026, downloadable in CSV format.